HERV-K102 and Pandemic Responses

Home
Archive
About

Sitemap - 2022 - HERV-K102 and Pandemic Responses

Wintertime

I don't believe it. Steve Kirsch is back on twitter!!

Have yourself a Merry Little Christmas...now.

Using Sleep Actigraphy for the Validation of Wellness

Genetic Evidence for HERV-K102 Deletion From the Orthologous Position on Chromosome 1q22 in the Extinct Hominins: Neanderthals and Denisovans

Concerns about Reverse Transcription and Integration of Spike mRNA Associated with COVID-19 mRNA Vaccination

Dr. Robert Malone's Comment Tonight Caught my Attention

Netherlands Excess Mortality Linked to the BiValent COVID-19 Vaccines

The British Parliament Does Not Consult The Office for National Statistics (ONS) on Serious Matters of Iatrogenic Death Associated with COVID-19 Vaccination

The Shocking Truth About COVID-19 Vaccines

The Significance of the Report of the November 1997 - National Forum on Xenotransplantation

Comments to CDC ACIP

Dr. John Campbell Reacts to Rob Roos's Tweet

It's Not OVER

The COVID-19 Vaccines Should Have Been Taken off the Market by Early February 2021 Vaccine Safety Experts Say

UK ONS Data: COVID-19 Vaccines

Surprisingly...Plain & Simple

An Urgent Call for HERV-K102 Research

By Late June of 2021 in England, There Were Early Warning Signals of mRNA COVID-19 Vaccine Harm

Dr. Mercola: A Superspreader of TRUTH

Don't Mess with Steve Kirsch

The Deafening Silence

A New Pandemic 2022

The All-Cause Mortality Test

Why Optimal Vitamin D is Essential to Fight SARS-CoV-2

Estimated Risks in England for 60+ Age Group January 2022 to May 2022

Raw Death Counts England January 2021-May 2022

Corrections to Stats August 7, 2022

Enhanced COVID-19 and Non-COVID-19 Deaths in the 70+ Age Group in ENGLAND in February 2022 Linked to 2-Dose COVID-19 Vaccination

We are at a Cross-Road with the Pandemic

Spike Toxicity in the UK Elder and Males from Alberta, Canada

Spike Toxicity - An Issue

The 15% Non-COVID-19 Excess All-cause Mortality of the UK

Overview of Mechanisms by Which HERV-K102 Trained Innate Immunity May Counteract the Replication of Enveloped RNA Pandemic Viruses

Did the second dose of mRNA COVID-19 vaccines select for the alpha and delta variants which prolonged the pandemic?

FDA VRBPAC Comment

Immunosenescence and COVID-19

How SARS-CoV-2 Targets Trained Immunity Involving HERV-K102 Particle Production

Significance of Trained Immunity Involving HERV-K102 Activation in Promoting Recovery from COVID-19

COVID-19 Lab-Leak Hypothesis Gains Momentum

Completed & Submitted a Literature Review Proposing HERV-K102 as the Elusive Correlate of Protection Against SARS-CoV-2 Infection

The New Rule: Under 50% VE (Vaccine Effectiveness) Could be Associated with an Absolute Increase in Infections, Hospitalizations and/or Deaths

OMICRON: The Best Natural Vaccine for Stimulating HERV-K102 Trained Innate Immunity?

Ivermectin's Universe

The Day 10 Post Symptom Onset Window for Seroconversion in COVID-19 Patients

Why was the mortality rate for the SARS-CoV-2 omicron variant wave higher than delta for many high vaccinating countries and lower for slow vaccinating countries?

Early COVID-19 Treatment With Anti-Acne and Other Drugs/Interventions

IVERMECTIN's Little Secret

The HERV-K Way to Keep Coronavirus (COVID-19) at Bay

A Smarter Pandemic Response

What might excess all cause mortality rates tell us about the emergence of SARS-COV-2 variants, and overall effects of vaccines on mortality during the pandemic in Canada?

On the Negative Effectiveness of COVID-19 "Adaptive Immunity" Vaccines in England

PART II: HOW SARS-COV-2 TARGETS HERV-K102 IN SEBOCYTES AND FOAMY MACROPHAGES

What you need to know about the HERV-K102 innate immunity protector system of macrophages against RNA pandemic viruses

Coming soon

© 2024 Dr. Marian Laderoute
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great culture